Cinnamon counteracts the negative effects of a high fat/high fructose diet on behavior, brain insulin signaling and Alzheimer-associated changes

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Anderson, Richard A ^a   Qin, Bolin ^a,b   Canini, Frederic ^c,e   Poulet, Laurent ^c,d   Roussel, Anne Marie ^d  

^a BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^b Integrity Nutraceuticals International   (United States)

^c Army Institute for Research in Biology   (France)

^d UNIV GRENOBLE ALPES   (France)

^e Ecole du Val de Grace   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CINNAMON EXTRACT; FRUCTOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLYCOGEN SYNTHASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TAU PROTEIN; FAT INTAKE; PLANT EXTRACT; SWEETENING AGENT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; BRAIN CORTEX; CARBOHYDRATE DIET; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ELEVATED PLUS MAZE TEST; GENE EXPRESSION; HIPPOCAMPUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; NEUROPROTECTION; NONHUMAN; RAT; Y-MAZE TEST; ADVERSE EFFECTS; ANIMAL; ANIMAL BEHAVIOR; CHEMISTRY; CINNAMOMUM ZEYLANICUM; DRUG EFFECTS; FAT INTAKE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHARMACOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

ALZHEIMER DISEASE; ANIMALS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; CINNAMOMUM ZEYLANICUM; DIETARY FATS; FRUCTOSE; HIPPOCAMPUS; INSULIN; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SWEETENING AGENTS;

EID: 84892639306     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083243     Document Type: Article

References (64)

1. Grundy SM (2008) Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28: 629-636. doi:10.1161/ATVBAHA.107.151092. PubMed: 18174459.
2. Convit A (2005) Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiol Aging 26 Suppl 1: 31-35. doi:10.1016/j. neurobiolaging.2005.09.018. PubMed: 16246463.
3. Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP et al. (2012) Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122: 1316-1338. doi:10.1172/JCI59903. PubMed: 22476197.
4. Craft S, Asthana S, Cook DG, Baker LD, Cherrier M et al. (2003) Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype. Psychoneuroendocrinology 28: 809-822. doi:10.1016/S0306-4530(02)00087-2. PubMed: 12812866.
5. Gupta A, Bisht B, Dey CS (2011) Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes. Neuropharmacology 60: 910-920. doi:10.1016/j.neuropharm.2011.01.033. PubMed: 21277873.
6. Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis 8: 247-268. PubMed: 16340083.
7. de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis 7: 45-61. PubMed: 15750214.
8. Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic. Journal of Alzheimer'S Disease - J Alzheimers Dis 9: 13-33.
9. de la Monte SM, Wands JR (2008) Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol 2: 1101-1113. PubMed: 19885299.
10. Stranahan AM, Norman ED, Lee K, Cutler RG, Telljohann RS et al. (2008) Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 18: 1085-1088. doi:10.1002/hipo. 20470. PubMed: 18651634.
11. Khan A, Safdar M, Khan Ali, Khattak KN, Anderson RA (2003) Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26: 3215-3218. doi:10.2337/diacare.26.12.3215. PubMed: 14633804.
12. Jarvill-Taylor KJ, Anderson RA, Graves DJ (2001) A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. J Am Coll Nutr 20: 327-336. doi: 10.1080/07315724.2001.10719053. PubMed: 11506060.
13. Wang JG, Anderson RA, Graham GM III, Chu MC, Sauer MV et al. (2007) The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study. Fertil Steril 88: 240-243. doi:10.1016/j.fertnstert. 2006.11.082. PubMed: 17296187.
14. Cao H, Polansky MM, Anderson RA (2007) Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys 459: 214-222. doi:10.1016/j.abb.2006.12.034. PubMed: 17316549.
15. Ziegenfuss TN, Hofheins JE, Mendel RW, Landis J, Anderson RA (2006) Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr 3:45-53
16. Peterson DW, George RC, Scaramozzino F, Lapointe NE, Anderson RA et al. (2009) Cinnamon Extract Inhibits Tau Aggregation Associated with Alzheimer's Disease. In Vitro - J Alzheimers Dis 17: 585-587.
17. Lu J, Zhang K, Nam S, Anderson RA, Jove R, Wen W (2010) Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling. Carcinogenesis 31: 481-488. PubMed: 19969552.
18. Qin B, Polansky MM, Anderson RA (2010) Cinnamon extract regulates plasma levels of adipose-derived factors and expression of multiple genes related to carbohydrate metabolism and lipogenesis in adipose tissue of fructose-fed rats. Horm Metab Res 42: 187-193. doi:10.1055/s-0029-1242746. PubMed: 19937569.
19. Qin B, Panickar KS, Anderson RA (2010) Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes. J Diabetes Sci Technol 4: 685-693. PubMed: 20513336.
20. Couturier K, Batandier C, Awada M, Hininger-Favier I, Canini F, Anderson RA et al. (2010) Cinnamon improves insulin sensitivity and alters the body composition in an animal model of the metabolic syndrome. Arch Biochem Biophys 501: 158-161. doi:10.1016/j.abb.2010.05.032. PubMed: 20515642.
21. Couturier K, Qin B, Batandier C, Awada M, Hininger-Favier I, Canini F et al. (2011) Cinnamon increases liver glycogen in an animal model of insulin resistance. Metabolism 60: 1590-1597. doi:10.1016/j.metabol.2011.03.016. PubMed: 21550075.
22. Anderson RA, Broadhurst CL, Polansky MM, Schmidt WF, Khan A et al. (2004) Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem 52: 65-70. doi:10.1021/jf034916b. PubMed: 14709014.
23. Killday KB, Davey MH, Glinski JA, Duan P, Veluri R, Proni G et al. (2011) Bioactive A-type proanthocyanidins from Cinnamomum cassia. J Nat Prod 74: 1833-1841. doi:10.1021/np1007944. PubMed: 21875098.
24. Cao H, Kelly MA, Kari F, Dawson HD, Urban JF Jr. et al. (2007) Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats. J Inflamm (Lond) 4: 1. doi:10.1186/1476-9255-4-1. PubMed: 17207279.
25. Cao H, Graves DJ, Anderson RA (2010) Cinnamon extract regulates glucose transporter and insulin-signaling gene expression in mouse adipocytes. Phytomedicine 17: 1027-1032. doi:10.1016/j.phymed.2010.03.023. PubMed: 20554184.
26. Preuss HG, Echard B, Polansky MM, Anderson R (2006) Whole cinnamon and aqueous extracts ameliorate sucrose-induced blood pressure elevations in spontaneously hypertensive rats. J Am Coll Nutr 25: 144-150. doi:10.1080/07315724.2006.10719525. PubMed: 16582031.
27. Dellu F, Fauchey V, Le MM, Simon H (1997) Extension of a new twotrial memory task in the rat: influence of environmental context on recognition processes. Neurobiol Learn Mem 67: 112-120. doi:10.1006/nlme.1997.3746. PubMed: 9075239.
28. Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R et al. (2011) Orally administrated cinnamon extract reduces beta-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models. PLOS ONE 6: e16564. doi: 10.1371/journal.pone.0016564. PubMed: 21305046.
29. Ryu BR, Ko HW, Jou I, Noh JS, Gwag BJ (1999) Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I. J Neurobiol 39: 536-546. doi:10.1002/(SICI)1097-4695(19990615)39:4. PubMed: 10380075.
30. Woods SC, Seeley RJ, Baskin DG, Schwartz MW (2003) Insulin and the blood-brain barrier. Curr Pharm Des 9: 795-800. doi: 10.2174/1381612033455323. PubMed: 12678878.
31. Schiöth HB, Craft S, Brooks SJ, Frey WH, Benedict C (2012) Brain insulin signaling and Alzheimer's disease: current evidence and future directions. Mol Neurobiol 46: 4-10. doi:10.1007/s12035-011-8229-6. PubMed: 22205300.
32. Kim B, Feldman EL (2012) Insulin resistance in the nervous system. Trends Endocrinol Metab 23: 133-141. doi:10.1016/j.tem.2011.12.004. PubMed: 22245457.
33. Benedict C, Brooks SJ, Kullberg J, Burgos J, Kempton MJ et al. (2012) Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly. Diabetes Care 35: 488-494. doi:10.2337/dc11-2075. PubMed: 22301128.
34. Parra MA, Abrahams S, Fabi K, Logie R, Luzzi S, Della SS (2009) Short-term memory binding deficits in Alzheimer's disease. Brain 132: 1057-1066. PubMed: 19293236.
35. Kosari S, Badoer E, Nguyen JC, Killcross AS, Jenkins TA (2012) Effect of western and high fat diets on memory and cholinergic measures in the rat. Behav Brain Res 235: 98-103. doi:10.1016/j.bbr.2012.07.017. PubMed: 22820146.
36. Bruehl H, Sweat V, Hassenstab J, Polyakov V, Convit A (2010) Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance. J Clin Exp Neuropsychol 32: 487-493. doi:10.1080/ 13803390903224928. PubMed: 20524222.
37. Crawford P (2009) Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med 22: 507-512. doi:10.3122/jabfm.2009.05.080093. PubMed: 19734396.
38. Akilen R, Tsiami A, Devendra D, Robinson N (2010) Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multiethnic Type 2 diabetic patients in the UK: a randomized, placebocontrolled, double-blind clinical trial. Diabet Med 27: 1159-1167. doi: 10.1111/j.1464-5491.2010.03079.x. PubMed: 20854384.
39. Lu T, Sheng H, Wu J, Cheng Y, Zhu J, Chen Y (2012) Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes. Nutr Res 32: 408-412. doi:10.1016/j.nutres.2012. 05.003. PubMed: 22749176.
40. Soulis G, Papalexi E, Kittas C, Kitraki E (2007) Early impact of a fat-enriched diet on behavioral responses of male and female rats. Behav Neurosci 121: 483-490. doi:10.1037/0735-7044.121.3.483. PubMed: 17592939.
41. Prasad A, Prasad C (1996) Short-term consumption of a diet rich in fat decreases anxiety response in adult male rats. Physiol Behav 60: 1039-1042. doi:10.1016/S0031-9384(96)00135-7. PubMed: 8873290.
42. White CL, Pistell PJ, Purpera MN, Gupta S, Fernandez-Kim SO et al. (2009) Effects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: contributions of maternal diet. Neurobiol Dis 35: 3-13. doi:10.1016/j.nbd.2009.04.002. PubMed: 19374947.
43. Stranahan AM, Norman ED, Lee K, Cutler RG, Telljohann RS et al. (2008) Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 18: 1085-1088. doi:10.1002/hipo. 20470. PubMed: 18651634.
44. Cruz AP, Frei F, Graeff FG (1994) Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49: 171-176. doi:10.1016/0091-3057(94)90472-3. PubMed: 7816869.
45. Souza CG, Moreira JD, Siqueira IR, Pereira AG, Rieger DK et al. (2007) Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like behavior. Life Sci 81: 198-203. doi: 10.1016/j.lfs.2007.05.001. PubMed: 17574275.
46. Legendre A, Harris RB (2006) Exaggerated response to mild stress in rats fed high-fat diet. Am J Physiol Regul Integr Comp Physiol 291: R1288-R1294. doi:10.1152/ajpregu.00234.2006. PubMed: 16793938.
47. Buwalda B, Blom WA, Koolhaas JM, van DG (2001) Behavioral and physiological responses to stress are affected by high-fat feeding in male rats. Physiol Behav 73: 371-377. doi:10.1016/S0031-9384(01)00493-0. PubMed: 11438364.
48. Park CR (2001) Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 25: 311-323. doi:10.1016/S0149-7634(01)00016-1. PubMed: 11445137.
49. Frisardi V, Solfrizzi V, Capurso C, Imbimbo BP, Vendemiale G et al. (2010) Is insulin resistant brain state a central feature of the metaboliccognitive syndrome? J Alzheimers Dis 21: 57-63. PubMed: 20421697.
50. Reger MA, Watson GS, Green PS, Baker LD, Cholerton B et al. (2008) Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis 13: 323-331. PubMed: 18430999.
51. Park CR, Seeley RJ, Craft S, Woods SC (2000) Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav 68: 509-514. doi:10.1016/S0031-9384(99)00220-6. PubMed: 10713291.
52. Cruz NF, Dienel GA (2002) High glycogen levels in brains of rats with minimal environmental stimuli: implications for metabolic contributions of working astrocytes. J Cereb Blood Flow Metab 22: 1476-1489. PubMed: 12468892.
53. Gibbs ME, Hutchinson DS (2012) Rapid turnover of glycogen in memory formation. Neurochem Res 37: 2456-2463. doi:10.1007/s11064-012-0805-2. PubMed: 22664636.
54. Brown AM, Ransom BR (2007) Astrocyte glycogen and brain energy metabolism. Glia 55: 1263-1271. doi:10.1002/glia.20557. PubMed: 17659525.
55. Gonzales MM, Tarumi T, Miles SC, Tanaka H, Shah F, Haley AP (2010) Insulin sensitivity as a mediator of the relationship between BMI and working memory-related brain activation. Obesity (Silver Spring) 18: 2131-2137. doi:10.1038/oby.2010.183. PubMed: 20814415.
56. Qutub AA, Hunt CA (2005) Glucose transport to the brain: a systems model. Brain Res Brain. Res Rev 49: 595-617. doi:10.1016/j.brainresrev.2005.03.002.
57. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH et al. (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316: 750-754. doi:10.1126/science. 1141736. PubMed: 17478722.
58. Takashima A (2012) GSK-3beta and memory formation. Front - Journal of Mol Neuroscience 5: 47. PubMed: 22536172.
59. Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V et al. (2008) Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372: 216-223. doi:10.1016/S0140-6736(08)61075-2. PubMed: 18640458.
60. Jiao L, Zhang X, Huang L, Gong H, Cheng B et al. (2013) Proanthocyanidins are the major anti-diabetic components of cinnamon water extract. Food Chem Toxicol 56: 398-405. doi:10.1016/j.fct.2013.02.049. PubMed: 23499750.
61. Irvine EE, Drinkwater L, Radwanska K, Al-Qassab H, Smith MA et al. (2011) Insulin receptor substrate 2 is a negative regulator of memory formation. Learn Mem 18: 375-383. doi:10.1101/lm.2111311. PubMed: 21597043.
62. Killick R, Scales G, Leroy K, Causevic M, Hooper C et al. (2009) Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice. Biochem Biophys Res Commun 386: 257-262. doi:10.1016/j.bbrc. 2009.06.032. PubMed: 19523444.
63. Stuart CA, Ross IR, Howell ME, McCurry MP, Wood TG et al. (2011) Brain glucose transporter (Glut3) haploinsufficiency does not impair mouse brain glucose uptake. Brain Res 1384: 15-22. doi:10.1016/j.brainres.2011.02.014. PubMed: 21316350.
64. Lu Z, Jia Q, Wang R, Wu X, Wu Y et al. (2011) Hypoglycemic activities of A- and B-type procyanidin oligomer-rich extracts from different Cinnamon barks. Phytomedicine 18: 298-302. doi:10.1016/j.phymed. 2010.08.008. PubMed: 20851586.